| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ce3d976927d5a567096775d1cd6f9ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74d098365c421137e36f64c58c41a981
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c56df974f88641d90872aa36728b2ef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60ace2549aa35aacd52f4d0c51b79c18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31f7416524170cbb5d9d6f6fc5ccb043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81b5a80503e762c44f77b23a60ce880e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2400-0487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2200-0621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2400-0457 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L7-525 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03F7-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate |
2018-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_249a525369ed5bc717e76d52b0381026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_badd7af6bd16eb91c9e93959ee2769b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cad1150c23ec2972b3fc9b786e819fcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6833353852614b15b7b96664c81ee335 |
| publicationDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10962518-B2 |
| titleOfInvention |
Dissolution test for sensitive drugs |
| abstract |
A method and apparatus for drug dissolution testing may include an overflow vessel with an overflow outlet port at a predetermined height from a bottom of the overflow vessel, a first water bath submerging the overflow vessel and configured to keep a temperature of the overflow vessel at a first predetermined temperature, a pressurized vessel containing a dissolution medium, a second water bath submerging the pressurized vessel and configured to keep the dissolution medium at a second predetermined temperature, a dissolution medium path with an output end connected in fluid communication with the flow cell and an input end attached in fluid communication to the pressurized vessel, where the dissolution medium path may transfer the dissolution medium from the pressurized vessel into the flow cell, a collection vessel connected to the overflow outlet port of the flow cell, and a third water bath submerging the collection vessel and configured to keep the collection vessel at a third predetermined temperature. |
| priorityDate |
2017-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |